GCTKGlucoTrack, Inc.

Nasdaq glucotrack.com


$ 2.34 $ 0.29 (14.1 %)    

Monday, 19-Aug-2024 15:19:02 EDT
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 2.3504
$ 2.33 x 100
-- x --
-- - --
$ 0.66 - $ 4.95
21,850
na
12.87M
$ 2.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-21-2021 03-31-2021 10-Q
15 04-13-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-19-2020 03-31-2020 10-Q
19 04-14-2020 12-31-2019 10-K
20 11-13-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 04-15-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-30-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-31-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-16-2015 09-30-2015 10-Q
37 08-14-2015 06-30-2015 10-Q
38 05-15-2015 03-31-2015 10-Q
39 03-31-2015 12-31-2014 10-K
40 11-14-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 glucotrack-announces-it-has-secured-4m-in-funding-from-its-leading-shareholder-to-support-the-upcoming-first-in-human-clinical-trial-of-its-blood-glucose-monitor

Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the des...

 glucotrack-announces-expansion-of-its-continuous-glucose-monitoring-technology-to-epidural-glucose-monitoring

Expansion offers the potential for continuous, discreet and simplified epidural glucose monitoring solutions for patients with ...

 glucotrack-announces-increased-sensor-longevity-for-its-implantable-continuous-blood-glucose-monitor

Computational modeling with The Technology Partnership shows sensor longevity beyond 3 years; 1 year longer than previously ann...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION